Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans.
Davidson MH, Voogt J, Luchoomun J, Decaris J, Killion S, Boban D, Glass A, Mohammad H, Lu Y, Villegas D, Neese R, Hellerstein M, Neff D, Musliner T, Tomassini JE, Turner S.
Davidson MH, et al. Among authors: neff d.
Atherosclerosis. 2013 Oct;230(2):322-9. doi: 10.1016/j.atherosclerosis.2013.08.006. Epub 2013 Aug 13.
Atherosclerosis. 2013.
PMID: 24075764
Clinical Trial.